Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 17:2024:10.17912/micropub.biology.001216.
doi: 10.17912/micropub.biology.001216. eCollection 2024.

In silico analysis of several frequent SLX4 mutations appearing in human cancers

Affiliations

In silico analysis of several frequent SLX4 mutations appearing in human cancers

Korey Bosart et al. MicroPubl Biol. .

Abstract

SLX4 is an interactor and activator of structure-specific exonuclease that helps resolve tangled recombination intermediates arising at stalled replication forks. It is one of the many factors that assist with homologous recombination, the major mechanism for restarting replication. SLX4 mutations have been reported in many cancers but a pan cancer map of all the mutations has not been undertaken. Here, using data from the Catalogue of Somatic Mutations in Cancers (COSMIC), we show that mutations occur in almost every cancer and many of them truncate the protein which should severely alter the function of the enzyme. We identified a frequent R1779W point mutation that occurs in the SLX4 domain required for heterodimerization with its partner, SLX1. In silico protein structure analysis of this mutation shows that it significantly alters the protein structure and is likely to destabilize the interaction with SLX1. Although this brief communication is limited to only in silico analysis, it identifies certain high frequency SLX4 mutations in human cancers that would warrant further in vivo studies. Additionally, these mutations may be potentially actionable for drug therapies.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest present.

Figures

Figure 1.
<b>Pan-cancer analysis of SLX4 mutations</b>
Figure 1. Pan-cancer analysis of SLX4 mutations
A . SLX4 mutations in all cancers are primarily coding. B . A map of SLX4 showing the relevant domains. The diagram was adapted from (Payliss et al., 2021). Shown on the diagram are truncating mutations (black) and high frequency mutations (>5) in red. C . Distribution of coding mutations (silent, missense, nonsense, InDel) by cancer type. D. (Top) Model showing location of WT R1779 residue (orange) interacting with the side chain of E1816 (yellow) through a salt-bridge (shown in dashed magenta lines). (Bottom) A model of the W1779 (orange) mutation with the loss of the E1816 (yellow) salt-bridge interaction. E . (Top) Electrostatic surface potential of the WT protein where the location of the R1779 is circled. (Bottom) Electrostatic surface potential of the R1779W mutant where the location of the W1779 residue is circled. Blue represents a basic or positive charge, red is an acidic or negative charge, white is neutral.

Similar articles

References

    1. Adamson AW, Ding YC, Steele L, Leong LA, Morgan R, Wakabayashi MT, Han ES, Dellinger TH, Lin PS, Hakim AA, Wilczynski S, Warden CD, Tao S, Bedell V, Cristea MC, Neuhausen SL. Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer. J Ovarian Res. 2023 Jul 17;16(1):141–141. doi: 10.1186/s13048-023-01234-x. - DOI - PMC - PubMed
    1. Alghoul E, Paloni M, Takedachi A, Urbach S, Barducci A, Gaillard PH, Basbous J, Constantinou A. Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. Mol Cell. 2023 Apr 13;83(10):1640–1658.e9. doi: 10.1016/j.molcel.2023.03.021. - DOI - PubMed
    1. Alter BP, Best AF. Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis. Breast Cancer Res Treat. 2020 Jun 2;182(2):465–476. doi: 10.1007/s10549-020-05710-6. - DOI - PubMed
    1. Catucci I, Colombo M, Verderio P, Bernard L, Ficarazzi F, Mariette F, Barile M, Peissel B, Cattaneo E, Manoukian S, Radice P, Peterlongo P. Sequencing analysis of SLX4/FANCP gene in Italian familial breast cancer cases. PLoS One. 2012 Feb 23;7(2):e31038–e31038. doi: 10.1371/journal.pone.0031038. - DOI - PMC - PubMed
    1. Chakraborty S, Schirmeisen K, Lambert SA. The multifaceted functions of homologous recombination in dealing with replication-associated DNA damages. DNA Repair (Amst) 2023 Aug 1;129:103548–103548. doi: 10.1016/j.dnarep.2023.103548. - DOI - PubMed

LinkOut - more resources